Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody
Danay Saavedra, Ana Laura Añé-Kourí, Egda M Llanez Gregorich, Jilma Mena, Patricia Lorenzo-Luaces, Henrry Diaz Londres, Aray Hernández Martínez, Jorge Jiménez Armada, Yamilka Hernández Sánchez, Yaneth Zamora González, Mayelín Troche, Loipa Medel, Mayra Ramos, Tania Crombet
Topics & Concepts
NimotuzumabMedicineImmune systemImmunologyAntibodyLymphocyteMonoclonal antibodyCoagulopathyInternal medicineCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Dermatological and COVID-19 studies